fluorobenzenes has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Li, X; Liu, Y; Sun, J; Sun, R; Tang, Y; Wang, D; Wu, H; Yang, Y; Zheng, Y; Zhou, Y | 1 |
1 other study(ies) available for fluorobenzenes and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
SHC004-221A1, a novel tyrosine kinase, potently inhibits T315I mutant BCR-ABL in chronic myeloid leukemia.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fluorobenzenes; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Purines; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |